期刊文献+

国外局部外用药控制膝骨关节炎疼痛的临床研究进展 被引量:16

下载PDF
导出
摘要 膝关节骨性关节炎(knee osteoarthritis,KOA)疼痛非常复杂,口服药物不良反应多,不利长期应用。本文介绍局部外用药用以控制KOA源性疼痛的现状。检索Pub Med、EMBASE、Cochrane临床对照试验库、Cochrane图书馆,检索时间均从1990年1月至2014年6月。根据局部外用药物用以治疗KOA的临床试验相关报道,共纳入16种药物,其中欧盟流通非甾体抗炎药物7种:酮洛芬、双氯芬酸、氟比洛芬酯、吡罗昔康透皮贴剂、布洛芬、吡罗昔康和尼氟灭酸凝胶;酰胺类局麻药物1种:利多卡因;阿片类药物2种:芬太尼和曲马多;草本药提取物4种:辣椒素、山金车、橄榄油和紫草科植物。外治法药物控制KOA疼痛,首推双氯芬酸、酮洛芬、吡罗昔康,起效快、安全性高。草本类药物橄榄油、山金车、辣椒素、紫草科植物萃取物可供选择。局部药物外治是KOA镇痛的重要选择,国外此方面研究方兴未艾,国内需及时跟进。
出处 《中国疼痛医学杂志》 CAS CSCD 2016年第2期133-136,共4页 Chinese Journal of Pain Medicine
基金 国家自然科学基金(81573993) 江苏省基础研究计划(自然科学基金BK20151589) 江苏省中医院周福贻全国名老中医工作室
  • 相关文献

参考文献24

  • 1Neogi T,Zhang Y.Epidemiology of osteoarthritis.Rheum Dis Clin North Am,2013,39(1):1-19.
  • 2Kon E,Filardo G,Drobnic M,et al.Non-surgical management of early knee osteoarthritis.Knee Surg Sports Traumatol Arthrosc,2012,20(3):436-449.
  • 3Shah S,Mehta V.Controversies and advances in nonsteroidal anti-inflammatory drug(NSAID)analgesia in chronic pain management.Postgrad Med J,2012,88(1036):73-78.
  • 4Varadi G,Zhu Z,Blattler T,et al.Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis.Pain Physician,2013,16(6):E749-762.
  • 5Conaghan PG,Dickson J,Bolten W,et al.A multicentre,randomized,placebo-and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Trans-fersome gel(IDEA-033)with ketoprofen-free vehicle(TDT 064)and oral celecoxib for knee pain associated with osteoarthritis.Rheumatology(Oxford),2013,52(7):1303-1312.
  • 6Komatsu T,Sakurada T.Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.Eur J Pharm Sci,2012,47(5):890-895.
  • 7Bookman AA,Williams KS,Shainhouse JZ.Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee:a randomized controlled trial.CMAJ,2004,171(4):333-338.
  • 8van Haselen RA,Fisher PA.A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee.Rheumatology(Oxford),2000,39(7):714-719.
  • 9Sengupta S,Velpandian T,Kabir SR,et al.Analgesic efficacy and pharmacokinetics of topical nimesulide gel in healthy human volunteers:double-blind comparison with piroxicam,diclofenac and placebo.Eur J Clin Pharmacol,1998,54(7):541-547.
  • 10Erdogan F,Ergun H,Gokay NS,et al.The diffusion of nimesulide gel into synovial fluid:a comparison between administration routes.Int J Clin Pharmacol Ther,2006,44(6):270-275.

二级参考文献14

  • 1Zaka R, Stokes D, Dion AS, et al. P5L mutation in Ank results in an increase in extracellular inorg- anic pyrophosphate during proliferation and nonm- ineralizing hypertrophy in stably transduced ATD C5 cells. Arthritis Res Ther, 2006, 8 : R164.
  • 2McDougall J J, Watkins L, Li Z, et al. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain, 2006, 123 : 98- 105.
  • 3Pulsatelli L, Pulsatelli L, Dolzani P, et al. Synovial expression of vasoactive intestinal peptide in poly- myalgia rheumatica. Clin Exp Rheumatol, 2006, 24 : 562 - 566.
  • 4Wyke B. The neurology of joints: a review of gene- ral principles. Ann R Coll Surg Engl, 1967, 41 : 25 50.
  • 5WallPD,MelzackR著.赵宝昌,崔秀云,主译.疼痛学.第三版.沈阳:辽宁教育出版社,2000:150.
  • 6Christensen SB. Osteoarthritis changes of bone, cartilage and synovial membrane in relation to bone scintigraphy. Acta Orthop Scand suppl, 1985, 56 : 214 - 243.
  • 7Kallakuri S, Singh A, Chert C, et al. Demonstrati- on of substance P, calcitonin gene-related peptide, and protein gene product 9.5 containing nerve fibers in human cervical facet joint capsules. Spine, 2004, 29 : 1182 - 1186.
  • 8Oku R, Satoh M, Fujii N, et al. Calcitonin gene- related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res, 1987, 403 : 350 - 354.
  • 9Pulsatelli L, Dolzani P, Silvestri T, et al. Synovial expression of vasoactiw intestinal peptide in pol- ymyalgia rheumatica. Clin Exp Rheumatol, 2006, 24 : 562 - 566.
  • 10Hernanz A, Medina S, Miguel E, et al. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regul Pept, 2003, 115 : 19 24.

共引文献4

同被引文献156

引证文献16

二级引证文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部